Institution identification

Institution ID

45967

Institution full name and acronym

Fondazione ReS (Ricerca e Salute), CINECA partner

Institution countries

Italy

Type of institution

Not-for-profit

Institution role

Researcher

Institution website

ENCePP partner

Yes
Institution description
Fondazione ReS (Ricerca e Salute - Research and Health Foundation), through the collaboration with CINECA (a non-profit Interuniversity Consortium made up of 70 Italian universities, 47 Italian public institutions, the Italian Ministry of Education and Ministry of University and Research), performs research activities in health care. The mission of ReS is to to create useful tools for planning and monitoring healthcare at different levels and for different stakeholders, based on real-world evidence from data describing the real-life practice. The tools created by ReS are useful to contribute to the improvement and completion of evidence-based and patient-centred clinical and policy choices, with a view of sustainability and promotion of the Italian public healthcare institutions. ReS operates in the fields of Real World Evidence, health economy, clinical and regulatory aspects in the following strategic areas: burden of disease in terms of healthcare resource consumption and integrated healthcare direct care costs in charge of the Italian National Healthcare Service (SSN); target populations of new technologies; description of care pathways; development of statistical models of integration between administrative data and clinical data (e.g., primary care databases); development of data collection platforms useful to the research in specific healthcare areas.
Institution details
Experience with collecting data directly from individual patients or respondents:
No
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact

Studies conducted by the institution

A methodology to assess the population size and estimate the needed resources for new licensed medications by combining clinical and administrative databases: The example of glycated haemoglobin in type 2 diabetes
A retrospective observational analysis of the realworld care pathway of people with hereditary transthyretin amyloidosis with polyneuropathy in Italy
Acute lower respiratory infections: real-world evidence of antibiotic prescription pattern and costs from a large administrative Italian database
Antiplatelet Therapy during the First Year after Acute Coronary Syndrome in a Contemporary Italian Community of over 5 Million Subjects
Cardiovascular events after exacerbations of chronic obstructive pulmonary disease: Results from the EXAcerbations of COPD and their OutcomeS in CardioVascular diseases study in Italy
Chronic Kidney Disease Eligible for SGLT2 Inhibitors Through the Integration of Italian Administrative and Primary Care Data
Clinical characteristics, use and switch of drugs for obstructive airway diseases among patients with COPD experiencing an exacerbation: a retrospective analysis of Italian administrative healthcare data
Coronary Artery Disease in Patients Older than 35 and Eligible for Cardiovascular Secondary Prevention: An Italian Retrospective Observational Analysis of Healthcare Administrative Databases
How many and who are patients with heart failure eligible to SGLT2 inhibitors? Responses from the combination of administrative healthcare and primary care databases
Identification of cases and estimate of direct costs of unresectable and advanced cutaneous squamous cell carcinoma: real-world data from a large Italian database
Insights into real-world treatment of cluster headache through a large Italian database: prevalence, prescription patterns, and costs
Italian healthcare resource consumption for patients on hemodialysis treated for chronic kidney disease-associated pruritus (CKD-aP)
Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment
Open Triple Therapy for Chronic Obstructive Pulmonary Disease: Patterns of Prescription, Exacerbations and Healthcare Costs From a Large Italian Claims Database
Prescription Pattern of Monoamine Oxidase B Inhibitors Combined with Levodopa: A Retrospective Observational Analysis of Italian Healthcare Administrative Databases
Prevalence, prescriptions, outcomes and costs of type 2 diabetic patients with or without prior coronary artery disease or stroke. A longitudinal 5-year claims-data analysis of over 7 million inhabitants
Primary Sjögren’s syndrome in Italy: real-world evidence of a rare disease through administrative healthcare data
Real world data on new users of atypical antipsychotics: characterization, prescription patterns, healthcare costs and early cardio-metabolic occurrences from a large Italian database
Real World Evidence in Oncology: an Italian examples-based expert opinion on advancing clinical and regulatory decision-making
Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naïve Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis